EMEA-001075-PIP04-15-M04
Key facts
| Invented name |
Evenity
|
| Active substance |
Romosozumab
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/0551/2021
|
| PIP number |
EMEA-001075-PIP04-15-M04
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of osteoporosis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
UCB Pharma S.A.
E-mail: UCBCares.UK@ucb.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|